Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT05617534
Other study ID # RSFG-21-ACC13
Secondary ID
Status Not yet recruiting
Phase
First received
Last updated
Start date January 10, 2023
Est. completion date December 31, 2023

Study information

Verified date December 2022
Source Children's Health Ireland at Crumlin
Contact Li Yen Ng, MB BCh BAO
Phone +353862341835
Email ngliyen@gmail.com
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The goal of this observational study is to learn about how a prescribed Exercise Training Program would affect children living with a Fontan circulation. From birth, the children who are born with single functioning ventricle will undergo 3-staged Fontan surgery to achieve a unique Fontan circulation, supported by one functioning ventricle. With advancement in surgical technique and medical care, there are increasing number of children living with Fontan circulating surviving into adulthood. A significant number of these individuals develop complications in their adulthood due to problems related to this unique circulation, including reduced exercise tolerance, heart failure, abnormal heart rhythm or premature death. Many of these children have acquired sedentary lifestyle, and may have lower self-perceived health related quality of life. Exercise training is a well-established therapy used in adult population with heart failure. It has been shown to be safe in children with congenital heart disease and with Fontan circulation, it improves their aerobic exercise capacity which is associated with better outcomes. The main question[s] it aims to answer are the impact of a Exercise Training program on: 1. Single ventricle function 2. Exercise capacity 3. Self-perceived quality of life 4. Skeletal muscle mass Participants will be given a 20-weeks exercise program, 3 sessions of 30 minutes workout weekly, to carry out at home. The following tests will be performed prior to starting and upon completion of the exercise program: - Echocardiogram - Cardiopulmonary exercise test - Body composition scan using a bio-impedance analyser - Quality of life questionnaires


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 30
Est. completion date December 31, 2023
Est. primary completion date December 31, 2023
Accepts healthy volunteers
Gender All
Age group 8 Years to 18 Years
Eligibility Inclusion Criteria: - Patients with Fontan circulation, age range 8 to 18 years - Ability to perform a cardiopulmonary exercise stress test (CPET) - Free from acute or chronic respiratory illness and/or conditions that might affect exercise performance - Who have had a Fontan operation at least six months prior. Exclusion Criteria: - Existing neuro-disability i.e. with paresis post cerebrovascular accident - Neurodevelopmental issue with inability to comply with commands. - Documented life-threatening arrhythmia without implantable cardioverter defibrillator - Moderate or severe atrio-ventricular valve regurgitation - Moderate or severe ventricular dysfunction by echocardiography exams - Acute inflammatory cardiac disease - documented coronary artery stenosis and/or myocardial ischaemia - Heart failure requiring hospitalisation in the past year - Evidence of systemic venous pathway obstruction by echocardiography or catheterisation - Resting oxygen saturation < 90% - Systemic ventricular outflow tract stenosis with peak resting systolic gradient > 50mmHg

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
Ireland Children's Health Ireland Dublin

Sponsors (2)

Lead Sponsor Collaborator
Children's Health Ireland at Crumlin CHI Research & Innovation Office

Country where clinical trial is conducted

Ireland, 

Outcome

Type Measure Description Time frame Safety issue
Primary Single ventricle Function By implementing a prescribed exercise training regime over a 20 week period, a change will be noted in ventricular function at the subclinical state using Echocardiography parameters. After a 20 week Exercise training program
Secondary Exercise Capacity By implementing a prescribed exercise training regime over a 20 week period, an improvement will be noted in functional exercise capacity, which will be objectively assessed using cardiopulmonary exercise test. After a 20 week Exercise training program
Secondary Self-perceived Quality of life - Generic By implementing a prescribed exercise training regime over a 20 week period, an improvement will be noted in self-reported quality of life, which will be assessed using validated QOL questionnaire - Using Paediatric Quality of Life Inventory, PedsQL v4.0 After a 20 week Exercise training program
Secondary Self-perceived Quality of life - Cardiac module By implementing a prescribed exercise training regime over a 20 week period, an improvement will be noted in self-reported quality of life, which will be assessed using validated QOL questionnaire - Using PedsQL Cardiac Module v3.0 After a 20 week Exercise training program
Secondary Skeletal muscle mass By implementing a prescribed exercise training regime over a 20 week period, an improvement will be noted in the skeletal muscle mass, which will be assessed using a non-invasive bio-impedance analyser. After a 20 week Exercise training program
See also
  Status Clinical Trial Phase
Completed NCT05934578 - Lymphatic Function in Patients With Fontan Circulation: Effect of Physical Training N/A
Recruiting NCT05563376 - Fontan-Sprechstunde N/A
Completed NCT04026542 - Factors Associated With Normal Exercise Capacity in Patients With Single Ventricle
Recruiting NCT04581668 - Impact of NAVA Ventilation on Brain Oxygenation and Perfusion in Children With Congenital Heart Disease N/A
Withdrawn NCT04035317 - Aesculus Hippocastanum L. on Fontan Circulation Phase 2
Completed NCT03818373 - Respiratory Drive in Patients With Univentricular Congenital Heart Disease N/A
Recruiting NCT05620030 - Prospective Evaluation of Univentricular Hearts N/A
Recruiting NCT05744934 - Interstage Monitoring Using an Implantable Loop Recorder: A Pilot Study Early Phase 1
Withdrawn NCT03997097 - Efficacy of Phosphodiesterase-type 5 Inhibitors in Patients With Univentricular Congenital Heart Disease Phase 3
Recruiting NCT04782232 - Registry to Assess the Safety and Feasibility of the Subpulmonary Support With the Novel Venous Cannula in Patients With Failing/Absence of the Right Heart
Completed NCT04394507 - Lymphatic Function in Patients With a Fontan Circulation From Brazil
Completed NCT02283255 - Cardiovascular, Pulmonary and Skeletal Muscle Evaluation Postoperative in Fontan Patients: Effects of Exercise Training N/A
Completed NCT04163653 - Lymphatic Morphology of Fontan Patients
Recruiting NCT05647213 - Autologous Induced Pluripotent Stem Cells of Cardiac Lineage for Congenital Heart Disease Phase 1
Recruiting NCT05454254 - Effect of Muscle Strengthening Training in Adults With Fontan Circulation N/A
Active, not recruiting NCT03379805 - Lymphatic Function in Patients With a Fontan-Kreutzer Circulation N/A